USFDA 483 to IPCA, Silvassa Cites Lapses
FDA has published the USFDA form 483 issued to Ipca Laboratories Ltd following inspection at
Warning letters, 483s, Recalls, Import Alerts, Audit observations
FDA has published the USFDA form 483 issued to Ipca Laboratories Ltd following inspection at
USFDA 483 / Sun Pharma, Mohali, India / FEI 3002807979 / USFDA Investigators: Justin A
USFDA Inspection of Intas, Matoda, Sanand facility in India (FEIÂ 3004011473); from 22 November 2022 to
Warning letter / Centrient India / MARCS-CMS 640196/ 320-23-06/ DECEMBER 07, 2022/ Observation 1 USFDA
USFDA issues Warning letter to DuPont Nutrition USA Inc., Newark, Delaware facility (FEI 3013947845) for